• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

发病年龄对重度抑郁症病程的影响。

Effect of age at onset on the course of major depressive disorder.

作者信息

Zisook Sidney, Lesser Ira, Stewart Jonathan W, Wisniewski Stephen R, Balasubramani G K, Fava Maurizio, Gilmer William S, Dresselhaus Timothy R, Thase Michael E, Nierenberg Andrew A, Trivedi Madhukar H, Rush A John

机构信息

Department of Psychiatry, University of California, San Diego, CA 92093, USA.

出版信息

Am J Psychiatry. 2007 Oct;164(10):1539-46. doi: 10.1176/appi.ajp.2007.06101757.

DOI:10.1176/appi.ajp.2007.06101757
PMID:17898345
Abstract

OBJECTIVE

This report assesses whether age at onset defines a specific subgroup of major depressive disorder in 4,041 participants who entered the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study.

METHOD

The study enrolled outpatients 18-75 years of age with nonpsychotic major depressive disorder from both primary care and psychiatric care practices. At study entry, participants estimated the age at which they experienced the onset of their first major depressive episode. This report divides the population into five age-at-onset groups: childhood onset (ages <12), adolescent onset (ages 12-17), early adult onset (ages 18-44), middle adult onset (ages 45-59), and late adult onset (ages > or =60).

RESULTS

No group clearly stood out as distinct from the others. Rather, the authors observed an apparent gradient, with earlier ages at onset associated with never being married, more impaired social and occupational function, poorer quality of life, greater medical and psychiatric comorbidity, a more negative view of life and the self, more lifetime depressive episodes and suicide attempts, and greater symptom severity and suicidal ideation in the index episode compared to those with later ages at onset of major depressive disorder.

CONCLUSIONS

Although age at onset does not define distinct depressive subgroups, earlier onset is associated with multiple indicators of greater illness burden across a wide range of indicators. Age of onset was not associated with a difference in treatment response to the initial trial of citalopram.

摘要

目的

本报告评估了在4041名参与缓解抑郁的序贯治疗方案(STAR*D)研究的参与者中,发病年龄是否能界定出一个特定的重度抑郁症亚组。

方法

该研究纳入了来自初级保健和精神科的18 - 75岁非精神病性重度抑郁症门诊患者。在研究开始时,参与者估计了他们首次经历重度抑郁发作的年龄。本报告将人群分为五个发病年龄组:儿童期发病(年龄<12岁)、青少年期发病(年龄12 - 17岁)、成年早期发病(年龄18 - 44岁)、成年中期发病(年龄45 - 59岁)和成年晚期发病(年龄≥60岁)。

结果

没有一个组明显与其他组不同。相反,作者观察到一种明显的梯度,与重度抑郁症发病较晚的人相比,发病年龄较早的人存在以下情况:从未结婚、社会和职业功能受损更严重、生活质量较差、有更多的医学和精神科合并症、对生活和自我的看法更消极、有更多的终生抑郁发作和自杀未遂经历,以及在本次发作中症状更严重和有自杀观念。

结论

虽然发病年龄并不能界定出不同的抑郁亚组,但较早发病与广泛指标中更高疾病负担中的多个指标相关。发病年龄与对西酞普兰初始试验的治疗反应差异无关。

相似文献

1
Effect of age at onset on the course of major depressive disorder.发病年龄对重度抑郁症病程的影响。
Am J Psychiatry. 2007 Oct;164(10):1539-46. doi: 10.1176/appi.ajp.2007.06101757.
2
Treatment outcomes for older depressed patients with earlier versus late onset of first depressive episode: a Sequenced Treatment Alternatives to Relieve Depression (STAR*D) report.首发抑郁发作早发与晚发的老年抑郁症患者的治疗结局:缓解抑郁的序贯治疗替代方案(STAR*D)报告
Am J Geriatr Psychiatry. 2008 Jan;16(1):58-64. doi: 10.1097/JGP.0b013e31815a43d7.
3
Does early-onset chronic or recurrent major depression impact outcomes with antidepressant medications? A CO-MED trial report.早发性慢性或复发性重度抑郁症是否会影响抗抑郁药物的治疗效果?一项 CO-MED 试验报告。
Psychol Med. 2013 May;43(5):945-60. doi: 10.1017/S0033291712001742. Epub 2012 Dec 11.
4
Substance use disorder comorbidity in major depressive disorder: an exploratory analysis of the Sequenced Treatment Alternatives to Relieve Depression cohort.重度抑郁症中的物质使用障碍共病:缓解抑郁症序列治疗替代方案队列的探索性分析
Compr Psychiatry. 2005 Mar-Apr;46(2):81-9. doi: 10.1016/j.comppsych.2004.07.025.
5
Prevalence and clinical correlates of irritability in major depressive disorder: a preliminary report from the Sequenced Treatment Alternatives to Relieve Depression study.重度抑郁症中易激惹的患病率及临床相关因素:缓解抑郁症序列治疗方案研究的初步报告
J Clin Psychiatry. 2005 Feb;66(2):159-66; quiz 147, 273-4.
6
Clinical differences among depressed patients with and without a history of suicide attempts: findings from the STAR*D trial.有和无自杀未遂史的抑郁症患者的临床差异:来自STAR*D试验的结果
J Affect Disord. 2007 Jan;97(1-3):77-84. doi: 10.1016/j.jad.2006.05.026. Epub 2006 Jul 7.
7
Patient-reported outcomes of quality of life, functioning, and depressive symptom severity in major depressive disorder comorbid with panic disorder before and after SSRI treatment in the star*d trial.STAR*D试验中,在使用选择性5-羟色胺再摄取抑制剂(SSRI)治疗之前和之后,伴有惊恐障碍的重度抑郁症患者报告的生活质量、功能和抑郁症状严重程度的转归。
Depress Anxiety. 2014 Aug;31(8):707-16. doi: 10.1002/da.22152. Epub 2013 Jul 16.
8
Do atypical features affect outcome in depressed outpatients treated with citalopram?伴有非典型特征的抑郁门诊患者应用西酞普兰治疗的结局是否受影响?
Int J Neuropsychopharmacol. 2010 Feb;13(1):15-30. doi: 10.1017/S1461145709000182. Epub 2009 Apr 3.
9
Association between treatment-emergent suicidal ideation with citalopram and polymorphisms near cyclic adenosine monophosphate response element binding protein in the STAR*D study.在STAR*D研究中,西酞普兰治疗引发的自杀意念与环磷酸腺苷反应元件结合蛋白附近多态性之间的关联。
Arch Gen Psychiatry. 2007 Jun;64(6):689-97. doi: 10.1001/archpsyc.64.6.689.
10
Clinical correlates of the worsening or emergence of suicidal ideation during SSRI treatment of depression: an examination of citalopram in the STAR*D study.SSRIs 治疗抑郁症过程中自杀意念恶化或出现的临床相关因素:STAR*D 研究中西酞普兰的考察。
J Affect Disord. 2009 Sep;117(1-2):63-73. doi: 10.1016/j.jad.2009.01.002. Epub 2009 Feb 14.

引用本文的文献

1
Adolescent depression, childhood maltreatment, and the immune system; a role for epigenetic aging?青少年抑郁症、童年期虐待与免疫系统;表观遗传衰老在其中起作用?
Brain Behav Immun Health. 2025 Jul 28;48:101080. doi: 10.1016/j.bbih.2025.101080. eCollection 2025 Oct.
2
Neurobiological subtypes of adolescent depression: a multimodal integration of morphometric similarity network and spatial transcriptomics.青少年抑郁症的神经生物学亚型:形态计量相似性网络与空间转录组学的多模态整合
Mol Psychiatry. 2025 Aug 2. doi: 10.1038/s41380-025-03133-7.
3
Biomarkers associated with treatment outcome in young people with depression: A systematic review.
抑郁症青少年治疗结果相关生物标志物:一项系统综述。
Neurosci Appl. 2024 Jul 2;3:104082. doi: 10.1016/j.nsa.2024.104082. eCollection 2024.
4
Impact of Age at Narcolepsy Onset on Sleep-Onset REM Periods in the Multiple Sleep Latency Test.发作性睡病发病年龄对多次睡眠潜伏期试验中睡眠起始快速眼动期的影响。
J Clin Med. 2025 Jun 19;14(12):4379. doi: 10.3390/jcm14124379.
5
Assessing a prediction model for depression risk using an early adolescent sample with self-reported depression.使用自我报告有抑郁症的青少年早期样本评估抑郁症风险预测模型。
JCPP Adv. 2024 Sep 3;5(2):e12276. doi: 10.1002/jcv2.12276. eCollection 2025 Jun.
6
Association of Sexual Dysfunction, Vitamin D, and Thyroid Levels with Suicidal Behavior Among Patients with Depressive Disorder: A Cross-sectional Study.抑郁症患者性功能障碍、维生素D及甲状腺水平与自杀行为的相关性:一项横断面研究
Indian J Psychol Med. 2025 Jun 1:02537176251339764. doi: 10.1177/02537176251339764.
7
Associations between appetite loss and clinical features as well as inflammatory cytokines in adolescents with major depressive disorder.重度抑郁症青少年食欲减退与临床特征及炎性细胞因子之间的关联。
Front Psychiatry. 2025 May 14;16:1583060. doi: 10.3389/fpsyt.2025.1583060. eCollection 2025.
8
A retrospective analysis of vortioxetine utilization in children and adolescents with major depressive disorder in clinical practice.临床实践中对患有重度抑郁症的儿童和青少年使用伏硫西汀的回顾性分析。
BMC Psychiatry. 2025 May 20;25(1):509. doi: 10.1186/s12888-025-06983-1.
9
Age of onset, sociodemographic, and clinical predictors of depression: a population-based study in Rural Southern Iran.抑郁症的发病年龄、社会人口统计学及临床预测因素:一项基于伊朗南部农村地区人群的研究。
BMC Public Health. 2025 May 17;25(1):1825. doi: 10.1186/s12889-025-22993-w.
10
The patient musician: a qualitative investigation of professional classical musicians who previously suffered from depression.患病音乐家:对曾患抑郁症的职业古典音乐家的质性研究
BMC Public Health. 2025 May 1;25(1):1612. doi: 10.1186/s12889-025-22656-w.